|
||||||||||||||
 |
||||||||||||||
|
Grants and Awards: AAAAI 2010 Honorary Awards
2009 AAAAI Allied Health Professionals Recognition Award
"In recognition of service to the allergy/immunology allied health community as a leader, mentor and educator." Dr. Conboy-Ellis is an educator and consultant based St. Petersburg, FL. Currently she is an Assistant Professor of Nursing at the University of Tampa. She teaches graduate and undergraduate pediatrics and leadership and management courses. She has volunteered in the Free Clinic in St Petersburg Florida to keep her clinical skills up to date, seeing patients with asthma and allergy and now works in Student Health at the University of Tampa. After receiving a diploma in nursing from Johns Hopkins Hospital School of Nursing in 1969, she went on to receive a master's degree in Child Health Nursing from the State University of New York at Buffalo in 1983, as well as a PhD in Epidemiology and Community Health from its School of Medicine in 1996. In 2000, she received a master's degree in Health Administration from the University of Florida. Dr. Conboy-Ellis is past- president of the Association of Asthma Educators and served on its national board for eight years. She has extensive background as a pediatric nurse practitioner and nursing coordinator of clinical research with the Division of Allergy/Clinical Immunology, Children's Hospital of Buffalo, NY, The Children's Hospital, Boston, MA, and most recently was an epidemiologist at All Children's Hospital in St Petersburg, FL. She was named a Fellow of the American Academy of Allergy, Asthma & Immunology, one of the first nurses to receive this status. She also received certification as an asthma educator (AE- C) in the first group certified in November 2002. She was named Asthma Educator of the Year by the Association of Asthma Educators in 2004. Dr Ellis is president of West Coast Council of Nurse Practitioners. She is advisor to the Student Nurses Association at the University of Tampa. She has published extensively and is a national speaker primarily on her lifelong clinical and research interest, caring for families with asthma and allergic disease. A member of Allied Health since the early 1980s, Dr. Conboy-Ellis has served as a committee member in allied health and was co chair of Allied Health Program Committee, Vice Chair of Allied Health and Past Chair of Allied Health from 2001-2007.She is a member of Health Delivery Education and Quality Interest Section. Dr. Ellis has served on the annual program committee for the past 5 years. Currently, she is chair of the Advanced Practice Program for Allied Health. She is past president of the Association of Asthma Educators and is Co-chair of Allied Health Programs for the American College of Allergy, Asthma and Immunology through 2009. She is married to Elliot F Ellis, MD, a past president of AAAAI and they reside in St Petersburg, FL and Boston, MA. Together they have five children and four grandchildren 2009 AAAAI Distinguished Clinician Award
"In recognition of significant contributions to the management of childhood asthma through the appropriate use of long-term control therapy, especially in corticosteroid therapy." Dr. Stanley Szefler is the Helen Wohlberg and Herman Lambert Chair in Pharmacokinetics, Head of Pediatric Clinical Pharmacology and Director of the Weinberg Clinical Research Unit/Pediatrics Section at National Jewish Health in Denver, CO. He is Professor of Pediatrics and Pharmacology at the University of Colorado Denver School of Medicine. Dr. Szefler received pharmacy and medical degrees from the State University of New York at Buffalo. He then received residency training in pediatrics, followed by fellowship training in clinical pharmacology and allergy-immunology at the Children's Hospital of Buffalo. His training in allergy/immunology was under Elliot Ellis, MD, clinical pharmacology with Edward Carr, MD and pharmacokinetics with William Jusko, PhD at the State University of New York at Buffalo. He moved to National Jewish in 1982 to help develop the childhood asthma research program. Dr. Szefler has focused his career on childhood asthma, especially pharmacotherapy. His most significant contributions are directed toward the appropriate use of long-term control therapy in asthma, including the application of biomarkers to individualize therapy. He is the Principal Investigator for the National Jewish sites of the National Heart, Lung, and Blood Institute's (NHLBI) Childhood Asthma Management Program (CAMP) and the NHLBI Childhood Asthma Research and Education (CARE) Network, and Co-Principal Investigator for the National Institute of Allergy and Infectious Diseases Inner-City Asthma Consortium (ICAC). He also is a Co-Investigator for the NHLBI Asthma Clinical Research Network (ACRN). For the past three years, he has directed a school-based asthma program for the Denver Public School system. This program seeks to define the prevalence and severity of asthma, identify those most significantly affected and to direct those children to state-of-the-art asthma care. Since 2000, Dr. Szefler has been a member of the Expert Panel for the National Heart, Lung, and Blood Institute's National Asthma Education and Prevention Program on "Guidelines for the Diagnosis and Management of Asthma." Since 1997, he has been a Deputy Editor for The Journal of Allergy and Clinical Immunology. He has published more than 350 scientific articles and co-edited books on severe asthma, childhood asthma, and pediatric allergy and immunology. His career in medicine has been supported by his wife, Christine, and two sons, David and Paul. He thanks his family and his many friends, colleagues and research staff in Buffalo, Denver and the NIH research networks for the opportunity to work with them and advance asthma care. 2009 AAAAI Distinguished Clinician Award
"In recognition of more than four decades of service to the allergy/immunology specialty by dedication to teaching residents and allergy/immunology fellows at Washington University; as well as work in anaphylaxis, asthma management and the understanding of oral tolerance." Dr. Phillip Korenblat is Professor of Clinical Medicine at Washington University School of Medicine. He obtained his undergraduate and Doctor of Medicine degrees from the University of Arkansas. Following graduation, Dr. Korenblat attended the residency training program at The Jewish Hospital in St. Louis, MO and then entered a fellowship program at the Scripps Clinic and Research Foundation in La Jolla, CA. Dr. Korenblat returned to St. Louis and established his private practice in 1966. Dr. Korenblat is the Co-Director of The Clinical Research Center, located on the campus of Barnes Jewish West County Hospital, and has completed 257 clinical research studies. Dr. Korenblat has published extensively, including co-editor of two editions of the textbook Allergy Theory and Practice. Within the 1984 edition, he published the first asthma guidelines for the management of asthma, introducing the concept of using the "mild, moderate, and severe classification." In 1968, Dr. Korenblat, with co-investigators, published the first evidence of tolerance in humans to oral ingested food antigen and in collaboration with co-investigators was the first to present data demonstrating the requirement of multiple doses of epinephrine for the treatment of anaphylaxis. Dr. Korenblat was the originator in 1989 of a community-based Asthma Center at Barnes Jewish West County Hospital, co-founder of the St. Louis AAFA Chapter and senior advisor to the Board for Washington University School of Medicine Residency Mentoring and Academic Career Development Program. Dr. Korenblat is the current Co-Chair of the AAAAI Allied Health Annual Meeting Program Committee and a member of the ART Board of Trustees. Dr. Korenblat is listed in "Best Doctors of America," as well as in "America's Top Doctors." Dr. Korenblat has received numerous awards including the 1986 Teacher of the Year from the Department of Medicine at Washington University School of Medicine, The Distinguished Service Award from the Washington University Medical Center Alumni Association, St. Louis chapter, AAFA's Orchid Award and in 1995 the Outstanding Volunteer Clinical Faculty Award by the American Academy of Allergy, Asthma and Immunology. In 2003, Dr. Korenblat received the "Outstanding Teaching Allergist" Award presented jointly by AAAAI and ACAAI. Dr. Korenblat has an active role in teaching Washington University School of Medicine Allergy Fellows and Residents. He was the founder of the Allergy Abroad, a program in its 26th year that occurs biannually at the most distinguished centers for asthma and allergy care and research around the world. 2009 AAAAI Distinguished Layperson Award
"In recognition of educating the public and scientific community toward a greater understanding of hereditary angioedema and the development of therapies to treat this disease." The Hereditary Angioedema Association (HAEA) represents a new breed of rare disease patient organizations that have been enabled by Internet's uncanny capacity for creating communications channels that result in online communities. What started out in 1999 as a technologically savvy patient's personal Internet page that chronicled a family's struggle to cope with hereditary angioedema (HAE) soon grew into a group that shared their HAE-related experiences through a Yahoo! e-mail service. The increasing sophistication of Internet search engines enabled more patients to find the fledgling HAE e-mail group, and the members banded together to form the HAEA. Today, the HAEA reaches over 6,500 patients, and has identified over 1,200 physicians that treat HAE patients. Indeed, these are exciting times for HAE patients who finally have access to an FDA approved non-steroidal therapy for preventing attacks, and face good prospects for having one or more new HAE therapies available in the very near future. As one might expect from a "digital age" organization that was conceived in cyberspace, the HAEA's web page (www.haea.org) serves as the principal focal point for information dissemination and interaction among our patient community. Going forward, we look to accelerate our growth and work with physician groups to craft a uniquely American treatment approach that enables patients to choose a therapeutic approach that best meets their needs. We will also continue to provide a range of patient services and work with all stakeholders to positively affect the quality of life for all of those afflicted by this debilitating disease. 2009 AAAAI Distinguished Service Award
"In recognition of leadership in the development of the AAAAI Strategic Training in Allergy Research (ST*AR) program, which has been instrumental in introducing PhD students and PhD post docs to allergy/immunology research careers." Dr. Estelle Simons is a Professor in the Department of Pediatrics and Child Health and in the Department of Immunology at the University of Manitoba. She served as the President of the American Academy of Allergy, Asthma & Immunology (AAAAI) in 2005-2006. She is a past-Chair of the AAAAI Asthma, Rhinitis and Other Respiratory Diseases Interest Section, and past or current Chair of many AAAAI committees and Task Forces. In addition, she has served on the World Allergy Organization's Board of Directors. She is a past-President of the Canadian Society of Allergy and Clinical Immunology, and a past-Chair of the Royal College Clinical Immunology Examining Board, the Royal College Clinical Immunology Specialty Committee and the Canadian Pediatric Society's Allergy Section. She was the founding President of the Manitoba Allergy Society. She is a Fellow of the Royal College of Physicians of Canada, the American College of Allergy Asthma and Immunology, and the American Academy of Pediatrics, and is also a member of the American Thoracic Society. She has authored or co-authored more than 470 peer-reviewed original articles, editorials, reviews and book chapters. She has also edited or co-edited six books, including Middleton's Allergy: Principles and Practice, 6th edition (2003) and 7th edition (2009). She has served on the editorial board of The Journal of Allergy and Clinical Immunology, The Annals of Allergy, Asthma and Immunology, The Medical Letter and other publications. On more than 270 occasions, she has been a visiting professor at universities, or an invited speaker at allergy meetings in North America, Europe, Asia, Australia/New Zealand, South America and Africa. During the course of her career, Dr. Simons has received many national and international honors and awards. These include the Medical Research Council Queen Elizabeth II Scientist Award (1975), the Canadian Society of Allergy and Clinical Immunology Research Award (1991), the Canadian Medical Association's 28th Medal of Service (1999), the Canadian Who's Who in Health Care Award (2001), the Anaphylaxis Canada Award (2003), the Commemorative Medal for the Queen's Golden Jubilee (2003) and the World Allergy Organization Scientific Achievement Award (2007). She has been listed in Best Doctors since 1990. She is a member of the Collegium Internationale Allergologicum. She is married to Keith Simons, PhD. Their children are Elinor Simons, MD, MSc, FAAAAI and Christopher Simons, DPhil. 2009 AAAAI Honorary Fellow Award
"In recognition of seminal work unraveling the surrogate mouse models that allow genetic approaches to sorting pathways of interest for TH2 type pulmonary inflammation. This work will improve the understanding of pulmonary inflammation to benefit the diagnosis and treatment of allergic and immunologic diseases." Dr. Erwin W. Gelfand has been Chairman of the Department of Pediatrics at National Jewish Health in Denver, CO for the last 22 years. He is Professor of Pediatrics and Immunology at the University of Colorado. He obtained his medical degree from McGill University in Montreal, Canada, and completed his pediatric residency and fellowship in Immunology at The Children's Hospital and Harvard Medical School in Boston. At the Hospital for Sick Children in Toronto and at the University of Toronto beginning in 1972, he advanced from assistant to associate to full professor of Pediatrics and Immunology and was head of the Division of Immunology, Allergy and Rheumatology at the Hospital for Sick Children from 1979-1987. In 1987, he moved to Denver to become Chairman of Pediatrics at National Jewish. Dr. Gelfand is a member of the American Academy for the Advancement of Science, the American Academy of Allergy, Asthma & Immunology, the American Association of Immunologists, the Clinical Immunology Society, the Society for Pediatric Research and the Society for Clinical Investigation. He is the recipient of the Mead Johnson Award for Research in Pediatrics, the McLaughlin Foundation Edward Gallie Visiting Professorship of the Royal College of Physicians and Surgeons of Canada, and the Lifetime Achievement award from National Jewish. He has been associate editor of numerous journals including American Journal of Respiratory Cell and Molecular Biology, the Journal of Allergy and Clinical Immunology and International Archives of Allergy and Immunology. Dr. Gelfand has had a long-standing interest in the diagnosis and management of genetic disorders of the immune system, having carried out some of the earliest bone marrow transplants in patients with severe combined immunodeficiency disease in the late 1960s. At the Hospital for Sick Children in Toronto, he developed one of the largest immunodeficiency and bone marrow transplant programs. His research interests there focused on signal transduction in lymphocytes. As well, he initiated many studies on the use of IVIG in antibody deficiency disorders and in different autoimmune and inflammatory diseases. In Denver, he pioneered some of the first studies in developing mouse models of asthma. This work contributed to our understanding of the many pathways that can result in altered airway function, eosinophilic airway inflammation and mucus hyper production. He has also characterized the important consequences of viral infection to the underlying allergic lung and how exposures to ozone and diesel exhaust particles can amplify lung allergic responses. More recently, he has focused on the characterization of CD8+ T cells in asthma pathogenesis, their resistance to corticosteroids and a potential role in steroid-insensitive asthma. As well, the important role of naturally-occurring T regulatory cells in attenuating allergic lung inflammation has been unraveled using these models with important implications for asthma management. He has received numerous grants from the National Institutes of Health, the Environmental Protection Agency and several foundations, and has published more than 650 papers in peer-reviewed journals. 2009 AAAAI Outstanding Volunteer Clinical Faculty Award
"In recognition of 22 years of service to the allergy/immunology training program at the University of Michigan; as a teacher and mentor to the allergy/immunology fellows and medical school house officers." Bernard L. (Ben) Gold, M.D., was born in Dallas, TX. He received a BA from the University of Montana, graduating with honors in botany. He was awarded his medical degree by Baylor College of Medicine in Houston, TX. Following an internship and residency in Internal Medicine at St. Joseph Mercy Hospital in Ann Arbor, MI, in 1984 he completed a Fellowship in Allergy and Clinical Immunology at the University of Michigan in Ann Arbor, at which time he entered private practice. He continues to practice privately in allergy and asthma in neighboring Ypsilanti, MI. In addition, he is a part-time physician at the University of Michigan's Student Health Service, where he serves as Director of the Allergy Clinic and where he also has a voluntary academic appointment as Adjunct Assistant Clinical Professor in the Division of Allergy in the Department of Internal Medicine at the University of Michigan Hospitals. In this capacity as voluntary Adjunct Assistant Clinical Professor, Dr. Gold has had the privilege of teaching medical students, residents and allergy fellows as they rotate through the Student Health Service. In his 22 years of service, he has trained more than 40 allergists and several hundred medical students and residents. He truly enjoys teaching and while he is fascinated by all aspects of allergy and asthma, he is especially pleased when the subject is insect allergy, a topic on which he presents annual lectures for the fellows and for which he enthusiastically gathers and photographs specimens throughout the year. 2009 AAAAI RSLAAIS Leadership Award
"Presented posthumously to recognize and honor Dr. Fournier's dedicated service and commitment as a leader, advocate and teacher to the Texas Allergy, Asthma and Immunology Society and to the AAAAI." Dr. Donald C. Fournier passed away after a short illness on February 9, 2008. He was 58 years old. He was a 1974 graduate of the University of Texas Medical Branch at Galveston and completed Internal Medicine residency (1974-1977) and Allergy/Immunology fellowship at Wilford Hall USAF Medical Center in San Antonio. He was certified by the American Board of Internal Medicine and the American Board of Internal Medicine and the American Board of Allergy and Immunology. He was a member and former president of the Texas Allergy, Asthma, Immunology Society and a member of the Louisiana Society of Allergy, Asthma, and Immunology; the American College of Allergy, Asthma, and Immunology; the American Academy of Allergy, Asthma & Immunology; the American Association of Certified Allergists; the Joint Council of Allergy, Asthma, and Immunology; the American Medical Association; and the American College of Chest Physicians. He was very active in the Texas Asthma Educators Certification Program and served as governor of the Regional, State, and Local Allergy, Asthma, and Immunology Region number 5. He was a member of the Editorial Board of the Allergy and Asthma Proceedings, the official journal of the RSLAAIS. Dr. Fournier was a retired Lieutenant Colonel in the United States Air Force Medical Corp. He was activated in 1991 to serve his country in Desert Storm. In addition to his solo private practice in Texarkana, TX, he actively participated in many scholarly activities. For many years, he was on the program planning committees for the Southwest Allergy Forum and the Eastern Allergy Conference. He was also a volunteer Clinical Faculty member in the Department of Internal Medicine of the University of Arkansas for Medical Sciences and in the Departments of Pediatrics and Internal Medicine at Louisiana State University Health Sciences Center in Shreveport. He contributed significantly to the allergy/immunology fellowship training program at LSUHSC for 20 years, with admirable degrees of dedication and distinction. 2009 AAAAI Special Recognition Award
"In recognition of an exemplary career devoted to immunologic disorders in children. Particularly for his well-known textbook on the subject, which emphasizes on human intravenous immune globulin, stem cell transplantation, the immunology of malnutrition and AIDS, all of which have benefited the scientific and patient communities." E. Richard Stiehm, MD, is a Distinguished Professor of Pediatrics at UCLA. He received BS and MD degrees from the University of Wisconsin, was an intern at Philadelphia General Hospital and a pediatric resident at the Babies Hospital in New York City. He was an immunology fellow at Wisconsin and UC San Francisco. Dr. Stiehm began his academic career at Wisconsin in 1995, and because of his wife's Midwest mold allergies, moved to UCLA in 1969. At UCLA, he was chief of Pediatric Immunology/Allergy until 2003, serving as the training director for over 50 fellows. Dr. Stiehm's research interests include neonatal immunology, immunoglobulin therapy, and primary and secondary immunodeficiencies including malnutrition and pediatric AIDS. He utilized elevated IgM levels to identify newborns with congenital infection and characterized the opsonic defects in the sera of premature infants. He participated in the first IVIG trial in immunodeficiency, used subcutaneous IG in patients with anaphylaxis to IVIG, and studied the effect of hyper immune HIV-IG and AZT in the prevention of maternal-infant HIV transmission. Dr. Stiehm identified the first US Case of HIV transmission by breast feeding in his patient Ariel Glaser, and helped the child's mother, Elizabeth, establish the Pediatric AIDS Foundation. His work in Ghana and Kenya delineated the immune defects in protein-calorie malnutrition. His studies on primary immunodeficiency include the use of bone marrow transplantation in patients with DiGeorge syndrome and cord blood transplantation in X-linked Hyper-IgM and X-linked lymphoprolifetative syndromes He is the author of over 450 articles, chapters and books. He is the chief editor of the text Immunologic Disorders in Infants and Children editions I to V, and is the editor of clinical immunology for UP-TO-DATE, the on-line compilation of current medical information. Dr. Stiehm was a Markle Scholar, and has received the Wisconsin Medical Alumni Citation Award, the E. Mead Johnson Award for Research in Pediatrics, the Outstanding Achievement Award of the Immune Deficiency Foundation, the UCLA Medical Alumni Medical Science Award, the Babies and Children's Hospital of New York Distinguished Alumni Award and the American Society for Microbiology's Abbott Award in Clinical and Diagnostic Immunology. |
|||||||||||||
|
© 1996-2010 · All Rights Reserved · American Academy of Allergy Asthma & Immunology |
||||||||||||||
